PHARMOUR
PHARMOUR, a leading name in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2005, the company has established itself as a key player in the development and distribution of innovative healthcare solutions, focusing on prescription medications and over-the-counter products. With a commitment to quality and efficacy, PHARMOUR offers a diverse range of core products, including advanced therapeutics and specialty pharmaceuticals that cater to various medical needs. The company is recognised for its unique approach to drug formulation and delivery, setting it apart in a competitive market. Notable achievements include multiple FDA approvals and a growing portfolio of patented technologies, solidifying PHARMOUR's position as a trusted provider in the healthcare sector. As it continues to expand its reach, PHARMOUR remains dedicated to improving patient outcomes through cutting-edge research and development.
DitchCarbon Score
How does PHARMOUR's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Leather Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PHARMOUR's score of 3 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PHARMOUR's reported carbon emissions
PHARMOUR, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the absence of data may indicate an opportunity for the company to enhance transparency and establish measurable climate commitments in line with industry standards. As the global focus on climate action intensifies, it is crucial for organisations like PHARMOUR to develop and communicate clear strategies for reducing their carbon footprint and contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PHARMOUR is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
